MiNK Therapeutics, Inc. (INKT)
↓ Download CSV| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Income | -$12.64M | -$11.29M | -$22.92M | -$30.95M | -$28.36M | -$14.64M | — |
| Net Income | -$12.49M | -$10.78M | -$22.46M | -$27.99M | -$30.21M | -$16.24M | — |
| EPS (Diluted) | $-2.93 | $-2.86 | $-6.54 | $-0.83 | $-1.16 | — | — |
| Total Assets | $14.24M | $5.72M | $4.55M | $21.47M | $40.24M | $4.56M | — |
| Shareholders' Equity | -$14.23M | -$19.59M | -$18.06M | -$401.3K | $23.78M | -$53.87M | -$36.33M |
| Cash & Equivalents | $13.36M | $4.58M | $3.37M | $19.64M | $38.89M | — | — |
| Operating Cash Flow | -$5.93M | -$9.56M | -$15.76M | -$18.87M | -$12.83M | -$8.34M | — |
| Capital Expenditures | — | — | $73.6K | $250.0K | $249.0K | $95.2K | — |
| Shares Outstanding | 4.27M | 3.77M | 3.44M | 33.67M | 26.03M | — | — |